Direkt zum Inhalt
Merck

Prednicarbate (dermatop): a review.

Journal of drugs in dermatology : JDD (2004-11-24)
Aditya K Gupta, Melody Chow
ZUSAMMENFASSUNG

Prednicarbate is a non-halogenated, double-ester derivative of prednisolone that has become of interest for the treatment of inflammatory skin diseases, for example atopic dermatitis. In the past, topical steroids have been a popular choice for treating these diseases; however, the potential for significant local and systemic adverse events, such as skin atrophy and hypothalamic-pituitary-adrenal (HPA) axis suppression have limited their use. Prednicarbate has been found to have a favorable benefit-risk ratio, with low skin atrophy potential, and a high anti-inflammatory action. Prednicarbate may be particularly advantageous when used intermittently in pediatric and elderly patients.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Prednicarbat für die Systemeignung A, European Pharmacopoeia (EP) Reference Standard
Prednicarbat, European Pharmacopoeia (EP) Reference Standard